Boris Pasche
Affiliations: | Integrated Graduate Program in the Life Sciences | Northwestern University, Evanston, IL |
Area:
Genetics, Cell BiologyGoogle:
"Boris Pasche"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Agyemang K, Johansen AM, Barker GW, et al. (2022) TGFBR1*6A as a modifier of breast cancer risk and progression: advances and future prospects. Npj Breast Cancer. 8: 84 |
| Sirkisoon SR, Carpenter RL, Rimkus T, et al. (2021) Correction: TGLI1 transcription factor mediates breast cancer brain metastasis via activating metastasis-initiating cancer stem cells and astrocytes in the tumor microenvironment. Oncogene |
| Cai Z, Li CF, Han F, et al. (2020) Phosphorylation of PDHA by AMPK Drives TCA Cycle to Promote Cancer Metastasis. Molecular Cell |
| Mehraein-Ghomi F, Liu L, Topaloglu U, et al. (2020) Abstract C002: Dysregulation of fatty acid metabolism by TP53 mutations underlies more aggressive endometrial cancers in African American women Cancer Epidemiology, Biomarkers & Prevention |
| Liu L, Mehraein-Ghomi F, Forbes E, et al. (2020) Abstract C001: TP53 mutations reprogram fatty acid metabolism and tumor microenvironment in African American patients with non-small cell lung cancer Cancer Epidemiology, Biomarkers & Prevention |
| Sirkisoon SR, Carpenter RL, Rimkus T, et al. (2019) TGLI1 transcription factor mediates breast cancer brain metastasis via activating metastasis-initiating cancer stem cells and astrocytes in the tumor microenvironment. Oncogene |
| Sharma S, Wu SY, Jimenez H, et al. (2019) Ca and CACNA1H mediate targeted suppression of breast cancer brain metastasis by AM RF EMF. Ebiomedicine |
| Dohm A, Su J, McTyre ER, et al. (2019) Identification of CD37, cystatin A, and IL-23A gene expression in association with brain metastasis: analysis of a prospective trial. The International Journal of Biological Markers. 1724600818803104 |
| Lima CMSPR, Alistar AT, Desnoyers RJ, et al. (2019) A phase I clinical trial of fluorouracil (5-FU) + devimistat (CPI-613) combination in previously treated patients (pts) with metastatic colorectal cancer (MCR). Journal of Clinical Oncology. 37 |
| Song Q, Hawkins GA, Wudel L, et al. (2019) Abstract 3391: Dissecting intratumoral cell-cell interactions in myeloid reprogramming by single cell RNA-seq Cancer Research. 79: 3391-3391 |